Inhalation
Rethinking Inhalation Drug Development
Justin Lacombe, Ph.D.; Komal Patel
Experic
PAO-06-25-CL-01Jun 23, 2025
Flexibility
Flexible CDMO Solutions — Reducing Risk and Accelerating Time to Market
Sheetal Muley, Ph.D.; Justin Lacombe, Ph.D.
Experic
PAO-04-25-CL-06May 23, 2025
Inhalation
Unparalleled Expertise and Transparency Drive a Unique Development, Manufacturing, and Clinical Supply Experience
David Wood
Experic
PAO-03-25-CL-04Apr 05, 2025
Respiratory Diseases
Developing a Novel Anti-Inflammatory for Patients with Severe Asthma
Robert Clarke, Ph.D
Kinaset Therapeutics
PAO-02-022-CL-13Mar 12, 2022